CASI Pharmaceuticals
CASI
#10383
Rank
HK$33.26 M
Marketcap
HK$1.62
Share price
0.00%
Change (1 day)
-90.83%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.61. In 2024 the company made an earnings per share (EPS) of -HK$19.97 a decrease over its 2023 EPS that were of -HK$15.76.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.618.21%
2024-HK$19.9726.73%
2023-HK$15.76-32.89%
2022-HK$23.4811.9%
2021-HK$20.98-38.44%
2020-HK$34.09-8.96%
2019-HK$37.4450%
2018-HK$24.9677.78%
2017-HK$14.045.88%
2016-HK$13.26-22.73%
2015-HK$17.16-76.09%
2014-HK$71.77318.18%
2013-HK$17.16-71.79%
2012-HK$60.8565.96%
2011-HK$36.66-50%
2010-HK$73.33-18.97%
2009-HK$90.49-63.64%
2008-HK$248.843.57%
2007-HK$240.26-60.56%
2006-HK$609.2497.22%
2005-HK$308.91-2.7%
2004-HK$317.49-45.59%
2003-HK$583.49-61.8%
2002-HK$1,527-25.52%
2001-HK$2,051-21.38%
2000-HK$2,60913.86%
1999-HK$2,291149.53%
1998-HK$918.1498.15%
1997-HK$463.3610.2%
1996-HK$420.46